Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: Associated with loss of function of Nav1.1

Wei Ping Liao, Yi Wu Shi, Yue Sheng Long, Yang Zeng, Tian Li, Mei Juan Yu, Tao Su, Ping Deng, Zhi Gang Lei, Shu Jun Xu, Wei Yi Deng, Xiao Rong Liu, Wei Wen Sun, Yong Hong Yi, Zao C. Xu, Shumin Duan

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Purpose: Generalized epilepsy with febrile seizures plus (GEFS+) and severe myoclonic epilepsy in infancy (SMEI) are associated with sodium channel α-subunit type-1 gene (SCN1A) mutations. Febrile seizures and partial seizures occur in both GEFS+ and SMEI; sporadic onset and seizure aggravation by antiepileptic drugs (AEDs) are features of SMEI. We thus searched gene mutations in isolated cases of partial epilepsy with antecedent FS (PEFS+) that showed seizure aggravations by AEDs. Methods: Genomic DNA from four patients was screened for mutations in SCN1A, SCN2A, SCN1B, and GABRG2 using denaturing high-performance liquid chromatography (dHPLC) and sequencing. Whole-cell patch clamp analysis was used to characterize biophysical properties of two newly defined mutants of Nav1.1 in tsA201 cells. Results: Two heterozygous de novo mutations of SCN1A (R946H and F1765L) were detected, which were proven to cause loss of function of Nav1.1. When the functional defects of mutants reported previously are compared, it is found that all mutants from PEFS+ have features of loss of function, whereas GEFS+ shows mild dysfunction excluding loss of function, coincident with mild clinical manifestations. PEFS+ is similar to SMEI clinically with possible AED-induced seizure aggravation and biophysiologically with features of loss of function, and different from SMEI by missense mutation without changes in hydrophobicity or polarity of the residues. Conclusions: Isolated milder PEFS+ may associate with SCN1A mutations and loss of function of Nav1.1, which may be the basis of seizure aggravation by sodium channel-blocking AEDs. This study characterized phenotypes biologically, which may be helpful in understanding the pathophysiologic basis, and further in management of the disease.

Original languageEnglish (US)
Pages (from-to)1669-1678
Number of pages10
JournalEpilepsia
Volume51
Issue number9
DOIs
StatePublished - Sep 2010

Keywords

  • Channelopathy
  • Febrile seizures
  • Partial epilepsy
  • SCN1A
  • Sodium channel

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: Associated with loss of function of Na<sub>v</sub>1.1'. Together they form a unique fingerprint.

  • Cite this

    Liao, W. P., Shi, Y. W., Long, Y. S., Zeng, Y., Li, T., Yu, M. J., Su, T., Deng, P., Lei, Z. G., Xu, S. J., Deng, W. Y., Liu, X. R., Sun, W. W., Yi, Y. H., Xu, Z. C., & Duan, S. (2010). Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: Associated with loss of function of Nav1.1. Epilepsia, 51(9), 1669-1678. https://doi.org/10.1111/j.1528-1167.2010.02645.x